Magnesium

Earn CME/CE in your profession:


Continuing Education Activity

Magnesium is indicated for a variety of diseases due to its variety of effects within the body. Administration of magnesium can be divided into FDA-approved and non-FDA-approved forms. Magnesium is also commonly used in over-the-counter products. This activity will highlight the mechanism of action, adverse event profile, pharmacology, monitoring, and relevant interactions of magnesium, pertinent for interprofessional team members in treating patients with conditions where magnesium is indicated.

Objectives:

  • Identify the physiological processes in which magnesium is involved.

  • Assess the indications for endogenously administered magnesium therapy.

  • Evaluate the contraindications and toxicity of magnesium therapy.

  • Communicate interprofessional team strategies for improving care coordination to properly use magnesium to improve patient outcomes in the varied scenarios where magnesium is effective.

Indications

Due to its various effects on the body, magnesium is indicated for various diseases. Magnesium can be administered in FDA-approved and non-FDA-approved forms. It is also commonly used in over-the-counter products.[1][2][3][4] Normal serum blood magnesium levels are between 1.8 and 2.2 mg/dL.

Hypomagnesemia: Magnesium Concentration of Less Than 1.8 mg/dL

Magnesium depletion can result from inadequate intake, decreased renal absorption, or impaired gastrointestinal absorption. Risk factors for hypomagnesemia include those with gastrointestinal disease, chronic diarrhea, proton pump inhibitor therapy, alcohol use disorder, and diuretic use, both loop and thiazide. It is common to see hypomagnesemia along with low levels of other electrolytes, such as hypokalemia and hypocalcemia. In patients with refractory hypokalemia or hypocalcemia, hypomagnesemia may be the reason. It is difficult to correct these electrolyte imbalances without first treating the magnesium imbalance.[5] Symptoms of hypomagnesemia correlate with the development of concurrent hypocalcemia. The signs include Trousseau sign, Chvostek sign, hyperreflexia, tremor, and muscle fasciculations. Patients may also experience vague symptoms such as nausea, vomiting, lethargy, and weakness. Severe hypomagnesemia, less than 1.25 mg/dL, can result in generalized tonic-clonic seizures.[5]

Eclampsia or Severe Pre-Eclampsia

Magnesium is given to those with severe pre-eclampsia to prevent seizures and those with eclampsia to control seizures.[6]

Constipation

Over-the-counter laxatives, such as Milk of Magnesia, commonly contain magnesium.

Pre-Term Labor (Off-Label Use)

Magnesium can be given as a tocolytic to stop the progression of pre-term labor.[5]

Arrhythmias (Off-Label Use)

Administration of magnesium is recommended in certain arrhythmias such as torsades de pointes, digoxin-associated arrhythmia, ventricular arrhythmias like ventricular fibrillation, and ventricular tachycardia.[7]

Asthma: Acute Severe Exacerbation (Off-Label Use)

Magnesium is recommended as adjunctive therapy for patients with severe, life-threatening exacerbation or refractory cases after 1 hour of intensive conventional therapy. Magnesium allows bronchial smooth muscle relaxation, aiding patients with status asthmatics.

Migraines: Over-the-Counter Supplementation 

The use of magnesium in migraines is limited at this moment. Hypomagnesemia has been found in patients with migraines. Supplemental magnesium is considered an inexpensive, simple preventive treatment option for some. However, the dosage required is above the daily requirement, thus potentially leading to hypermagnesemia. The American Academy of Neurology and the American Headache Society have stated that magnesium therapy is “probably effective” for migraine prevention.[8]

Mechanism of Action

Like other electrolytes, magnesium's role in the body is diverse and complex. Its action mechanism depends on which organ system is involved and its formulation.Physiology of Magnesium

Magnesium is the fourth most common cation in the body. Most magnesium is intracellular; it is the second most common intracellular cation following potassium. Magnesium plays a vital role in over 300 reactions involving metabolism. It involves hormone receptor binding, muscle contraction, neural activity, neurotransmitter release, vasomotor tone, and cardiac excitability. It is necessary to transport potassium and calcium across the cell membrane actively. ATP is dependent on magnesium for proper functioning.[5]

Effects of Magnesium

Gastrointestinal

Oral magnesium promotes defecation via the osmotic retention of fluids. It is also used in over-the-counter antacids.[5]

Cardiovascular

Magnesium acts as a natural calcium channel blocker, a cofactor of the Na-K-ATP pump. Magnesium helps control atrioventricular node conduction. Therefore, hypomagnesemia can cause myocardial excitability, resulting in arrhythmias such as ventricular tachycardia and torsades de pointes.[5]

Neurological system

Magnesium depresses the central nervous system while producing anticonvulsant effects. At neuromuscular junctions, it inhibits the release of acetylcholine, thus blocking peripheral neuromuscular transmission.[5]

Reproductive system

Magnesium is used as a tocolytic during pre-term labor. Magnesium stimulates calcium reuptake by the sarcoplasmic reticulum, which promotes muscle relaxation and vasodilation. For pre-term labor, magnesium decreases the calcium within the uterine muscle.[5]

Musculoskeletal system

Magnesium is a cofactor of parathyroid hormone synthesis. With hypomagnesemia, concurrent hypoparathyroidism ensues. Hypoparathyroidism can lead to decreased calcium and eventually lead to osteopenia or osteoporosis.[5]

Respiratory system

Magnesium administration can cause bronchial smooth muscle relaxation. The cause of smooth muscle relaxation is unclear. It is thought to be either by inhibiting calcium, histamine, or acetylcholine release. There may also be a synergist effect with the concurrent use of beta-agonists.[5]

Hemostasis of magnesium

Roughly 50% of magnesium is located in bone, 25% in muscle, and the remainder in soft tissue, serum, and red blood cells. Like other electrolytes, magnesium can be classified as ionized, protein-bound, or bound to anions. Ionized magnesium has the most biological activity. The intestine, bone, and kidney maintain magnesium homeostasis. Like calcium, magnesium is absorbed through the intestine, stored in the bone, and excreted through the kidneys. Magnesium absorption is inversely proportional to the concentration within the body; if there are low magnesium levels, more magnesium is absorbed.

Administration

Magnesium can be administered in various ways. Dietary intake is the primary source of magnesium for a healthy individual. The recommended daily intake varies with gender and age. Green leafy vegetables, fish, legumes, and whole grains are good sources of magnesium. Magnesium comes in various salts and forms, including magnesium oxide, magnesium citrate, magnesium sulfate, magnesium hydroxide, and magnesium gluconate. Treatment can be via oral magnesium salts or intravenous or intramuscular magnesium sulfate. Intravenous or intramuscular magnesium sulfate is given for severe hypomagnesemia or those unable to tolerate or adhere to oral therapy. Patients with alcohol use disorder are treated empirically to avoid hypomagnesemia. The clinician must increase the dose for patients with renal insufficiency to adjust for the increase in renal loss.[5] The clinician must also address concurrent hypokalemia or hypocalcemia.

Adverse Effects

Adverse reactions are associated with magnesium’s effect on the neuromuscular and cardiovascular systems and can vary depending on the formulation. Effects can include the following:

Serious Adverse Events:

  • Cardiovascular collapse
  • Respiratory depression or paralysis
  • Hypothermia
  • Depressed cardiac function
  • Pulmonary edema

Common Adverse Events:

  • Flushing
  • Hypotension
  • Vasodilation
  • Impaired reflexes
  • Abdominal pain
  • Diarrhea
  • Flatulence
  • Nausea/vomiting
  • Respiratory depression
  • Electrolyte disorders (hypocalcemia, hyperkalemia)
  • Hypermagnesemia [9]

Hypermagnesemia can be a serious adverse event, particularly regarding cardiology effects; see the Toxicity section for more information. 

Contraindications

For contraindications, factors to consider are renal function, pregnancy, and neuromuscular disease. It is crucial to assess renal function before giving magnesium. Renal failure can cause decreased magnesium excretion, which can lead to toxicity. Closely monitor magnesium levels in patients with reduced renal function.[2] Patients with neuromuscular disease, such as myasthenia gravis, must be closely monitored to see if they are being given magnesium. Magnesium inhibits the release of acetylcholine, which can cause deterioration. Magnesium is considered class D for pregnancy. Skeletal demineralization, hypocalcemia, and hypermagnesemia are seen with long-term use, more than 5 to 7 days, of magnesium, which is necessary for pre-term labor treatment. There are no contraindications for magnesium supplements with other prescriptions. However, various drugs increase or decrease the concentration of either magnesium or the prescribed medication. Magnesium may be used in pregnancy and lactation; there is no expected risk of fetal or infant harm based on limited data in humans.

Monitoring

Hypermagnesemia may occur from overdose. While administering magnesium, the level of magnesium must be monitored. Serum magnesium levels and those of other electrolytes such as calcium and potassium can be monitored.

Toxicity

Hypermagnesemia: Serum Magnesium Concentration Greater than 2.6 mg/dL

Hypermagnesemia is a potential effect of administering magnesium. If too much magnesium is administered too quickly, hypermagnesemia may ensue. Symptoms include vasodilation causing flushing, hypotension, hyporeflexia, and respiratory depression. With a magnesium concentration above 6 mg/dL, electrocardiogram changes can consist of PR prolongation, widening of QRS, and peaked T waves. Cardiac arrest occurs whenever levels are above 15 mg/dL.[7][9][5] Hypermagnesemia is less common than hypomagnesemia. The most significant cause of hypermagnesemia is renal failure causing increased retention of magnesium. It can also occur in the overuse of magnesium-containing laxatives and antacids.[2] Treatment for hypermagnesemia includes calcium gluconate, diuresis, or dialysis. Maintaining circulatory and respiratory support for those with severe hypermagnesemia is important. Intravenous furosemide is the diuretic of choice, as it increases magnesium excretion.[10][5]

Enhancing Healthcare Team Outcomes

Magnesium is a vital mineral for many bodily functions. However, unless patients are diagnosed with hypomagnesemia, this mineral should not be empirically recommended by the prescribing clinicians, including MDs, DOs, NPs, and PAs. These days, many people consume magnesium supplements because of a false understanding of how to correct the condition. Excessive magnesium intake is not safe either, as it can lead to hypotension, hyporeflexia, and respiratory depression. With a magnesium concentration above 6 mg/dL, electrocardiogram changes can include PR prolongation, widening of QRS, and peaked T waves. Cardiac arrest occurs whenever levels are above 15 mg/dL. When intravenous magnesium is administered, the nurse should constantly monitor the vital signs, especially blood pressure.[10] 

While magnesium is generally safe, given the potential for severe issues in specific cases, the interprofessional team needs to be aware of the patient's supplemental magnesium intake and record such in the patient's health record. This way, the team can make medical decisions based on complete and accurate data. It is incumbent on each interprofessional team member to provide input based on their area of expertise and counsel the patient on the appropriate use of the drug. Pharmacists need to examine the possibility of drug-drug interactions and report to the prescriber as appropriate. An interprofessional approach involving clinicians, mid-level practitioners, pharmacists, and nursing staff collaborating on the activities and openly sharing case information provides the safest and most successful patient care.


Details

Author

Mary J. Allen

Editor:

Sandeep Sharma

Updated:

2/20/2023 8:40:28 PM

References


[1]

Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. International journal of molecular sciences. 2019 Mar 18:20(6):. doi: 10.3390/ijms20061351. Epub 2019 Mar 18     [PubMed PMID: 30889804]


[2]

Xiong J, He T, Wang M, Nie L, Zhang Y, Wang Y, Huang Y, Feng B, Zhang J, Zhao J. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis. Journal of nephrology. 2019 Oct:32(5):791-802. doi: 10.1007/s40620-019-00601-6. Epub 2019 Mar 19     [PubMed PMID: 30888644]

Level 1 (high-level) evidence

[3]

Moslehi M, Arab A, Shadnoush M, Hajianfar H. The Association Between Serum Magnesium and Premenstrual Syndrome: a Systematic Review and Meta-Analysis of Observational Studies. Biological trace element research. 2019 Dec:192(2):145-152. doi: 10.1007/s12011-019-01672-z. Epub 2019 Mar 18     [PubMed PMID: 30880352]

Level 1 (high-level) evidence

[4]

Chenard CA, Rubenstein LM, Snetselaar LG, Wahls TL. Nutrient Composition Comparison between the Low Saturated Fat Swank Diet for Multiple Sclerosis and Healthy U.S.-Style Eating Pattern. Nutrients. 2019 Mar 13:11(3):. doi: 10.3390/nu11030616. Epub 2019 Mar 13     [PubMed PMID: 30871265]


[5]

Swaminathan R. Magnesium metabolism and its disorders. The Clinical biochemist. Reviews. 2003 May:24(2):47-66     [PubMed PMID: 18568054]


[6]

Cox AG,Marshall SA,Palmer KR,Wallace EM, Current and emerging pharmacotherapy for emergency management of preeclampsia. Expert opinion on pharmacotherapy. 2019 Feb 1;     [PubMed PMID: 30707633]

Level 3 (low-level) evidence

[7]

Guess J, Hubel K, Wiggins A, Madigan CG, Bunin J. Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man. The American journal of case reports. 2018 Dec 20:19():1515-1518. doi: 10.12659/AJCR.912326. Epub 2018 Dec 20     [PubMed PMID: 30568157]

Level 3 (low-level) evidence

[8]

Karimi N, Razian A, Heidari M. The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study. Acta neurologica Belgica. 2021 Feb:121(1):167-173. doi: 10.1007/s13760-019-01101-x. Epub 2019 Feb 23     [PubMed PMID: 30798472]

Level 1 (high-level) evidence

[9]

Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, Caruso MG, Notarnicola M, Reddavide R, Stubbs B, Solmi M, Maggi S, Vaona A, Firth J, Smith L, Koyanagi A, Dominguez L, Barbagallo M. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. European journal of nutrition. 2020 Feb:59(1):263-272. doi: 10.1007/s00394-019-01905-w. Epub 2019 Jan 25     [PubMed PMID: 30684032]

Level 1 (high-level) evidence

[10]

Garber A, Rao PM, Rajakumar C, Dumitrascu GA, Rousseau G, Posner GD. Postpartum Magnesium Sulfate Overdose: A Multidisciplinary and Interprofessional Simulation Scenario. Cureus. 2018 Apr 7:10(4):e2446. doi: 10.7759/cureus.2446. Epub 2018 Apr 7     [PubMed PMID: 29888150]